Study of phenolic compounds in the Feverfew Herb by TLC and HPLC methods
DOI:
https://doi.org/10.24959/ubphj.19.225Keywords:
feverfew, herb, Aster family, thin layer chromatography, high performance liquid chromatography, flavonoids, hydroxycinnamic acidsAbstract
Topicality. The search of new plant sources of biologically active substances is an actual issue for the pharmaceutical science. The feverfew (Tanacetum parthenium (L.) Schultz Bip) is one of the prospective species of the Aster family. Its chemical composition mainly consists of phenolic compounds and sesquiterpene lactones. According to the latest data of the foreign sources feverfew herb phenolic compounds stipulate a prominent anti-inflammatory effect. This species is successfully used to treat the chronic inflammatory diseases of the connective tissue. Therefore, the determination of the qualitative composition and quantitative content in the samples of domestic feverfew raw material is actual.
Aim. To determinate the qualitative composition and quantitative content of phenolic compounds in the feverfew herb.
Materials and methods. The object was the feverfew herb collected in July 2017 on the territory of the Botanical garden of the National University of Pharmacy. The qualitative composition and quantitative content were determinated by the thin layer chromatography (TLC) and high performance liquid chromatography (HPLC) methods.
Results and discussion. Chlorogenic and cichoric acids zones, luteolin and luteolin7-glucoside in comparison with
their zones of reference standards were identified by TLC method. 12 compounds were identified and determinated by HPLC method. Hydroxycinnamic acids, namely 3,5-dicaffeoylquinic acid (1.575 %), 4,5-dicaffeoylquinic acid (1.308 %) and chlorogenic acid (0.784 %) were accumulated in the feverfew herb in the greatest amount. Among flavonoids, apigenin-7-glucoside (0.071 %) and kaempferol (0.041 %) prevailed.
Conclusions. For the first time the qualitative composition and quantitative content in the feverfew herb were determinated by TLC and HPLC methods. The high content of the phenolic compounds in the plant raw material attests to the opportunity of feverfew herb standardization by such classes as hydroxycinnamic acids and flavonoids. The data obtained attest to the perspective creating a medicine with the high anti inflammatory activity based on the feverfew herb.
References
Williams, C. A., Harborne, J. B., Geiger, H., Hoult, J. R. (1999). The flavonoids of Tanacetum parthenium and T. vulgare and their anti–inflammatory properties. Phytochemistry, 51, 417–423. https://doi.org/10.1016/S0031-9422(99)00021-7
Long, C., Sauleau, P., David, B., Lavaud, C., Cassabois, V., Ausseil, F., & Massiot, G. (2003). Bioactive flavonoids of Tanacetum parthenium revisited. Phytochemistry, 64 (2), 567–569. https://doi.org/10.1016/S0031-9422(03)00208-5
Pareek, A., Suthar, M., Rathore, G., & Bansal, V. (2011). Feverfew (Tanacetum parthenium L.) : A systematic review. Pharmacognosy Reviews, 5 (9),
https://doi.org/10.4103/0973-7847.79105
Rezaei, F., Jamei, R., & Heidari, R. (2017). Evaluation of the Phytochemical and Antioxidant Potential of Aerial Parts of Iranian Tanacetum parthenium. Pharmaceutical Sciences, 23 (2), 136–142. https://doi.org/10.15171/ps.2017.20
Williams, C. A., Hoult, J. R. S., Harborne, J. B., Greenham, J., & Eagles, J. (1995). A biologically active lipophilic flavonol from Tanacetum parthenium. Phytochemistry, 38 (1), 267–270. https://doi.org/10.1016/0031-9422(94)00609-w
Shynkovenko, I. L., Ilyina, T. V., Goryacha, O. V., Kovalyova, A. M., Komissarenko, A. М., Shemchuk, N. S., & Golembiovska, O. I. (2018). Phenolic compounds of the liquid extract from cleavers herb (galium aparine l.). Vìsnik Farmacìï, 3 (95), 19–24. https://doi.org/10.24959/nphj.18.2213
Derzhavna Farmakopeia Ukrainy : v 3 t. (2015). Derzhavne pidpryiemstvo “Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv”. Kharkiv : Derzhavne pidpryiemstvo “Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv”, 3, 732.
Santos, F. M., Malafaia, C. A., Simas, D. L. R., Paulino, A. B., Muzitano, M. F., Simas, N. K., … Leal, I. C. R. (2019). Phenolic compounds from Tocoyena bullata mart (Rubiaceae) with inhibitory activity in mast cells degranulation. Natural Product Research, 1–4. https://doi.org/10.1080/14786419.2018.1560281
Naveed, M., Hejazi, V., Abbas, M., Kamboh, A. A., Khan, G. J., Shumzaid, M., XiaoHui, Z. (2018). Chlorogenic acid (CGA): A pharmacological review
and call for further research. Biomedicine & Pharmacotherapy, 97, 67–74. https://doi.org/10.1016/j.biopha.2017.10.064
Nabavi, S. F., Braidy, N., Gortzi, O., Sobarzo– Sanchez, E., Daglia, M., Skalicka–Woźniak, K., & Nabavi, S. M. (2015). Luteolin as an anti-inflammatory and neuroprotective agent : A brief review. Brain Research Bulletin, 119, 1–11. https://doi.org/10.1016/j.brainresbull.2015.09.002
Wu, G., Li, J., Yue, J., Zhang, S., & Yunusi, K. (2017). Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma. Molecular Medicine Reports, 17 (2), 2456–2464 https://doi.org/10.3892/mmr.2017.8185
Palombo, R., Savini, I., Avigliano, L., Madonna, S., Cavani, A., Albanesi, C., … Terrinoni, A. (2016). Luteolin–7–glucoside inhibits IL–22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model. Cell Death & Disease, 7 (8), 2344–2344. https://doi.org/10.1038/cddis.2016.201
Song, Y. S., & Park, C. M. (2014). Luteolin and luteolin–7–O-glucoside strengthen antioxidative potential through the modulation of Nrf2/MAPK mediated HO–1 signaling cascade in RAW 264.7 cells. Food and Chemical Toxicology, 65, 70–75. https://doi.org/10.1016/j.fct.2013.12.017
Downloads
Published
Issue
Section
License
Copyright (c) 2019 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
